New proficiency testing facility
LGC Standards has opened a new facility at Chamberhall Green, Bury, UK. The new, purpose-built site will provide a centre of excellence for the operation of the company?s proficiency testing service.
LGC Standards has opened a new facility at Chamberhall Green, Bury, UK. The new, purpose-built site is situated adjacent to the new Greater Manchester Police divisional headquarters and will provide a centre of excellence for the operation of the company’s proficiency testing service.
“It is reassuring,” said Peter Fahy, chief constable of Greater Manchester Police, “to know that such a service exists to ensure that forensic testing laboratories supplying Greater Manchester Police can regularly monitor the quality of their results.”
Brian Brookman, general manager, LGC Standards Proficiency Testing, said, “This move to much larger, modern premises, housing our laboratory, despatch and administrative functions, is a key milestone in the development of our business. It will allow us to continue our growth plans, adding new schemes to our portfolio, and will give us the opportunity to further improve the service we offer to our customers.”
For more information on the company’s proficiency testing services visit www.lgcpt.com
Mitigating High Sample Volume Consumption in AAV Aggregate Analysis Using a Biozen™ dSEC-7 by SEC-FL
April 15th 2024This application note showcases a Biozen dSEC-7 SEC chemistry/fluorescence detector solution, offering reliable AAV aggregate analysis in under 10 minutes with as little as 0.5 µL of sample. Across four AAV serotypes, resolution between monomer and aggregates remains consistently high, emphasizing Biozen dSEC-7's efficiency and ability to maintain accurate detection at minimal injection volumes. Ideal for routine testing, this solution ensures precise measurement of a CQA with streamlined sample consumption.
Adeno-Associated Virus (AAV) Serotype Screen Using a Biozen™ dSEC-7 Size Exclusion Column
April 15th 2024With its 700 Å large pore silica particle and hydrophilic diol-type surface chemistry, Biozen dSEC-7 provides excellent resolution of monomer from dimer peaks in under 8 minutes across four different AAV serotypes. This capability is crucial for optimizing gene therapy biopharmaceuticals, ensuring thorough analytical scrutiny to select the most appropriate serotype(s) for enhanced therapeutic outcomes and immunogenic profiles.
